Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies.

Vela D.

Front Oncol. 2018 Nov 27;8:547. doi: 10.3389/fonc.2018.00547. eCollection 2018. Review.

2.

Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology.

Vela D.

Biofactors. 2018 Nov 21. doi: 10.1002/biof.1468. [Epub ahead of print] Review.

PMID:
30461080
3.

The Dual Role of Hepcidin in Brain Iron Load and Inflammation.

Vela D.

Front Neurosci. 2018 Oct 15;12:740. doi: 10.3389/fnins.2018.00740. eCollection 2018. Review.

4.
5.

Spirulina supplementation during the transition period by grazing dairy cattle at tropical highland conditions.

Garcés CN, Vela D, Mullo A, Cabezas V, Alvear A, Ponce CH.

Trop Anim Health Prod. 2019 Feb;51(2):477-480. doi: 10.1007/s11250-018-1691-7. Epub 2018 Aug 17.

PMID:
30120707
6.

[Triorchidism in the differential diagnosis of scrotal masses].

Casal-Beloy I, García-González M, Vela D, Pais E.

An Pediatr (Barc). 2019 Jan;90(1):61-62. doi: 10.1016/j.anpedi.2018.02.020. Epub 2018 Apr 9. Spanish. No abstract available.

7.

HbA1C, finding the right target in 2018.

Vela D.

Diabetes Metab Syndr. 2018 Jul;12(4):607-608. doi: 10.1016/j.dsx.2018.03.020. Epub 2018 Mar 31. No abstract available.

PMID:
29622471
8.

Hepcidin, an emerging and important player in brain iron homeostasis.

Vela D.

J Transl Med. 2018 Feb 7;16(1):25. doi: 10.1186/s12967-018-1399-5. Review.

9.

Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.

Vela D, Vela-Gaxha Z.

Exp Mol Med. 2018 Feb 2;50(2):e436. doi: 10.1038/emm.2017.273. Review.

10.

Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Vela D.

Lab Invest. 2018 Mar;98(3):315-326. doi: 10.1038/labinvest.2017.111. Epub 2017 Oct 23. Review.

PMID:
29058707
11.

Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine.

Vela D, Leshoski J, Vela Z, Jakupaj M, Mladenov M, Sopi RB.

BMC Endocr Disord. 2017 Aug 25;17(1):53. doi: 10.1186/s12902-017-0204-4.

12.

Low Hepcidin in Type 2 Diabetes Mellitus: Examining the Molecular Links and Their Clinical Implications.

Vela D, Sopi RB, Mladenov M.

Can J Diabetes. 2018 Apr;42(2):179-187. doi: 10.1016/j.jcjd.2017.04.007. Epub 2017 Jun 26. Review.

PMID:
28662967
13.

The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus.

Vela D, Leshoski J, Gjorgievska ES, Hadzi-Petrushev N, Jakupaj M, Sopi RB, Mladenov M.

Oman Med J. 2017 May;32(3):195-200. doi: 10.5001/omj.2017.37.

14.

Diagnosis of Thin-Capped Fibroatheromas in Intravascular Optical Coherence Tomography Images: Effects of Light Scattering.

Phipps JE, Hoyt T, Vela D, Wang T, Michalek JE, Buja LM, Jang IK, Milner TE, Feldman MD.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003163. doi: 10.1161/CIRCINTERVENTIONS.115.003163.

15.

Inflammatory myofibroblastic duodenal tumor: A rare cause of massive intestinal bleeding.

González MG, Vela D, Álvarez M, Caramés J.

Cancer Biomark. 2016 Mar 11;16(4):555-7. doi: 10.3233/CBM-160597.

PMID:
27002758
16.

Drosophila Females Undergo Genome Expansion after Interspecific Hybridization.

Romero-Soriano V, Burlet N, Vela D, Fontdevila A, Vieira C, García Guerreiro MP.

Genome Biol Evol. 2016 Feb 12;8(3):556-61. doi: 10.1093/gbe/evw024.

17.

Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft.

Aboshady I, Raad I, Vela D, Hassan M, Aboshady Y, Safi HJ, Buja LM, Khalil KG.

J Vasc Surg. 2016 Dec;64(6):1805-1814. doi: 10.1016/j.jvs.2015.09.061. Epub 2015 Nov 25.

18.

Preserving Staffing Resources As a System: Nurses Leading Operations and Efficiency Initiatives.

Hill KS, Higdon K, Porter BW, Rutland MD, Vela DK.

Nurs Econ. 2015 Jan-Feb;33(1):26-35.

PMID:
26214935
19.

Dual-modality fiber-based OCT-TPL imaging system for simultaneous microstructural and molecular analysis of atherosclerotic plaques.

Wang T, McElroy A, Halaney D, Vela D, Fung E, Hossain S, Phipps J, Wang B, Yin B, Feldman MD, Milner TE.

Biomed Opt Express. 2015 Apr 10;6(5):1665-78. doi: 10.1364/BOE.6.001665. eCollection 2015 May 1.

20.

Detection of plaque structure and composition using OCT combined with two-photon luminescence (TPL) imaging.

Wang T, McElroy A, Halaney D, Vela D, Fung E, Hossain S, Phipps J, Wang B, Yin B, Feldman MD, Milner TE.

Lasers Surg Med. 2015 Aug;47(6):485-94. doi: 10.1002/lsm.22366. Epub 2015 May 27.

PMID:
26018531
21.

Method for sectioning and sampling hearts for histologic evaluation after delivery of biological agents by transendocardial injection.

Vela D, Gahremanpour A, Buja LM.

Cardiovasc Pathol. 2015 Sep-Oct;24(5):304-9. doi: 10.1016/j.carpath.2015.04.005. Epub 2015 Apr 18.

PMID:
26002556
22.

Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes.

Kim H, Kee PH, Rim Y, Moody MR, Klegerman ME, Vela D, Huang SL, McPherson DD, Laing ST.

Ultrasound Med Biol. 2015 Jun;41(6):1701-10. doi: 10.1016/j.ultrasmedbio.2015.02.002. Epub 2015 Mar 24.

23.

Macrophages and intravascular OCT bright spots: a quantitative study.

Phipps JE, Vela D, Hoyt T, Halaney DL, Mancuso JJ, Buja LM, Asmis R, Milner TE, Feldman MD.

JACC Cardiovasc Imaging. 2015 Jan;8(1):63-72. doi: 10.1016/j.jcmg.2014.07.027. Epub 2014 Nov 5.

24.

Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes.

Kee PH, Kim H, Huang S, Laing ST, Moody MR, Vela D, Klegerman ME, McPherson DD.

Ultrasound Med Biol. 2014 Jun;40(6):1167-76. doi: 10.1016/j.ultrasmedbio.2013.12.013. Epub 2014 Mar 5.

25.

A genome-wide survey of genetic instability by transposition in Drosophila hybrids.

Vela D, Fontdevila A, Vieira C, García Guerreiro MP.

PLoS One. 2014 Feb 20;9(2):e88992. doi: 10.1371/journal.pone.0088992. eCollection 2014.

26.

Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.

Kim H, Kee PH, Rim Y, Moody MR, Klegerman ME, Vela D, Huang SL, McPherson DD, Laing ST.

Atherosclerosis. 2013 Dec;231(2):252-60. doi: 10.1016/j.atherosclerosis.2013.09.026. Epub 2013 Oct 5.

27.

Safety and feasibility of mapping and stem cell delivery in the presence of an implanted left ventricular assist device: a preclinical investigation in sheep.

Zheng Y, Sampaio LC, Li K, Silva GV, Cabreira-Hansen M, Vela D, Segura AM, Bovè C, Perin EC.

Tex Heart Inst J. 2013;40(3):229-34.

28.

Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction.

Gahremanpour A, Vela D, Zheng Y, Silva GV, Fodor W, Cardoso CO, Baimbridge F, Fernandes MR, Buja LM, Perin EC.

Xenotransplantation. 2013 Mar-Apr;20(2):110-22. doi: 10.1111/xen.12026. Epub 2013 Mar 13.

PMID:
23489741
29.

Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.

Sutton JT, Ivancevich NM, Perrin SR Jr, Vela DC, Holland CK.

Ultrasound Med Biol. 2013 May;39(5):813-24. doi: 10.1016/j.ultrasmedbio.2012.12.008. Epub 2013 Mar 1.

30.

Complete penoscrotal transposition: A three-stage procedure.

Somoza I, Palacios MG, Mendez R, Vela D.

Indian J Urol. 2012 Oct;28(4):450-2. doi: 10.4103/0970-1591.105775.

31.

Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.

Bhavane R, Badea C, Ghaghada KB, Clark D, Vela D, Moturu A, Annapragada A, Johnson GA, Willerson JT, Annapragada A.

Circ Cardiovasc Imaging. 2013 Mar 1;6(2):285-94. doi: 10.1161/CIRCIMAGING.112.000119. Epub 2013 Jan 24.

32.

Leydig cell tumour: enucleation as a therapeutic choice in a case with atypical symptoms.

García M, Dargallo T, Palacios M, Carames J, Gómez J, Sacristán F, Vela D.

Arch Esp Urol. 2012 Dec;65(10):897-9. English, Spanish.

PMID:
23269338
33.

Left ventricular markers of global dyssynchrony predict limited exercise capacity in heart failure, but not in patients with preserved ejection fraction.

Bajraktari G, Batalli A, Poniku A, Ahmeti A, Olloni R, Hyseni V, Vela Z, Morina B, Tafarshiku R, Vela D, Rashiti P, Haliti E, Henein MY.

Cardiovasc Ultrasound. 2012 Sep 11;10(1):36. doi: 10.1186/1476-7120-10-36.

34.

Insulin resistance improves metabolic and contractile efficiency in stressed rat heart.

Harmancey R, Lam TN, Lubrano GM, Guthrie PH, Vela D, Taegtmeyer H.

FASEB J. 2012 Aug;26(8):3118-26. doi: 10.1096/fj.12-208991. Epub 2012 May 18.

35.

A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection.

Aboshady I, Raad I, Shah AS, Vela D, Dvorak T, Safi HJ, Buja LM, Khalil KG.

J Vasc Surg. 2012 Sep;56(3):794-801. doi: 10.1016/j.jvs.2012.02.008. Epub 2012 May 10.

36.

A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure.

Ramani R, Vela D, Segura A, McNamara D, Lemster B, Samarendra V, Kormos R, Toyoda Y, Bermudez C, Frazier OH, Moravec CS, Gorcsan J 3rd, Taegtmeyer H, McTiernan CF.

J Am Coll Cardiol. 2011 Nov 22;58(22):2270-8. doi: 10.1016/j.jacc.2011.08.041.

37.

Body temperature circadian rhythm variability corresponds to left ventricular systolic dysfunction in decompensated cardiomyopathic hamsters.

Ahmed A, Gondi S, Cox C, Zheng M, Mohammed A, Stupin IV, Wang S, Vela D, Brewer A, Elayda MA, Buja LM, Ward Casscells S, Wilson JM.

J Card Fail. 2011 Nov;17(11):937-43. doi: 10.1016/j.cardfail.2011.07.004.

PMID:
22041331
38.

Ultrasound-enhanced rt-PA thrombolysis in an ex vivo porcine carotid artery model.

Hitchcock KE, Ivancevich NM, Haworth KJ, Caudell Stamper DN, Vela DC, Sutton JT, Pyne-Geithman GJ, Holland CK.

Ultrasound Med Biol. 2011 Aug;37(8):1240-51. doi: 10.1016/j.ultrasmedbio.2011.05.011.

39.

Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia.

Perin EC, Silva GV, Vela DC, Zheng Y, Baimbridge F, Gahremanpour A, Quan X, Hahn W, Kim J, Wood K, Kitamura M.

J Card Fail. 2011 Jul;17(7):601-11. doi: 10.1016/j.cardfail.2011.03.004. Epub 2011 Apr 22.

PMID:
21703533
40.

Adaptation of the AFLP technique as a new tool to detect genetic instability and transposition in interspecific hybrids.

Vela D, Guerreiro MP, Fontdevila A.

Biotechniques. 2011 Apr;50(4):247-50. doi: 10.2144/000113655.

41.

[Role of alpha antagonists in uncoordinated micturition syndrome in childhood].

Molina Vázquez ME, Somoza Arguibay I, Palacios MG, Gómez Veiras JR, González M, Tellado M, Pais E, Dargallo T, Vela D.

Cir Pediatr. 2010 Oct;23(4):236-40. Spanish.

PMID:
21520557
42.

Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques.

Aboshady I, Cody DD, Johnson EM, Gahremanpour A, Vela D, Khalil KG, Dupont HL, Willerson JT, Buja LM, Gladish GW.

Int J Cardiol. 2012 May 3;156(3):295-302. doi: 10.1016/j.ijcard.2010.11.011. Epub 2010 Dec 24.

43.

Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair.

Buja LM, Vela D.

J Am Coll Cardiol. 2010 Nov 16;56(21):1693-700. doi: 10.1016/j.jacc.2010.06.041. Review.

44.

Current status of the role of stem cells in myocardial biology and repair.

Buja LM, Vela D.

Cardiovasc Pathol. 2011 Sep-Oct;20(5):297-301. doi: 10.1016/j.carpath.2010.08.004. Epub 2010 Sep 16. Review.

PMID:
20846881
45.

[Quality of life in children operated on for anal atresia].

Molina ME, Lema A, Palacios MG, Somoza I, Gómez Veiras J, Tellado MG, Pais E, Dargallo T, Vela D.

Cir Pediatr. 2010 Jan;23(1):19-23. Spanish.

PMID:
20578572
46.

Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model.

Hitchcock KE, Caudell DN, Sutton JT, Klegerman ME, Vela D, Pyne-Geithman GJ, Abruzzo T, Cyr PE, Geng YJ, McPherson DD, Holland CK.

J Control Release. 2010 Jun 15;144(3):288-95. doi: 10.1016/j.jconrel.2010.02.030. Epub 2010 Mar 2.

47.

Return to the fetal gene program: a suggested metabolic link to gene expression in the heart.

Taegtmeyer H, Sen S, Vela D.

Ann N Y Acad Sci. 2010 Feb;1188:191-8. doi: 10.1111/j.1749-6632.2009.05100.x. Review.

48.

[Correction of lop ear using minimally invasive approach].

Palacios MG, Somoza I, Lema A, Molina ME, Veiras JG, Tellado M, Ríos J, Dargallo T, Pais E, Vela D.

Cir Pediatr. 2009 Jul;22(3):115-8. Spanish.

PMID:
19957855
49.

Markers of autophagy are downregulated in failing human heart after mechanical unloading.

Kassiotis C, Ballal K, Wellnitz K, Vela D, Gong M, Salazar R, Frazier OH, Taegtmeyer H.

Circulation. 2009 Sep 15;120(11 Suppl):S191-7. doi: 10.1161/CIRCULATIONAHA.108.842252.

50.

[Therapeutic approach of enuresis based on the differentiation of the enuretic syndrome and monosymptomatic enuresis].

García Palacios M, Somoza I, Lema A, Molina ME, Gómez Veiras J, Tellado M, Dargallo T, Pais E, Vela D.

Cir Pediatr. 2009 Apr;22(2):100-2. Spanish.

PMID:
19715135

Supplemental Content

Support Center